Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitzalis, M. V.
Right arrow Articles by Rizzon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitzalis, M. V.
Right arrow Articles by Rizzon, P.
(Chest. 1998;114:185-191.)
© 1998 American College of Chest Physicians

β-Blocker Effects on Respiratory Sinus Arrhythmia and Baroreflex Gain in Normal Subjects

Maria Vittoria Pitzalis MD, PhD1; Filippo Mastropasqua MD1; Francesco Massari MD1; Andrea Passantino MD1; Paolo Totaro MD1; Cinzia Forleo MD1; and Paolo Rizzon MD1

1 From the Institute of Cardiology, University of Bari, Bari, Italy, and the "Salvatore Maugeri" Foundation IRCCS, Cassano Medical Centre, Cassano, Italy

Study objective: The results of studies on the effect of β-adrenergie blockade on respiratory sinus arrhythmia (RSA) are discordant. The aim of this study was to verify whether chronic β-adrenergic blockade is capable of increasing RSA, and therefore vagal outflow, and to analyze whether the mechanism of action is central or peripheral.

Participants and design: Twenty normal subjects (28±2 years old) were randomized to receive a hydrophilic (nadolol) β-blocker, a lipophilic (metoprolol) β-blocker, and placebo.

Measurements: After 1 week of therapy, a spectral analysis was made of the variability in heart rate and systolic BP during controlled breathing at 16 breaths/min. The high-frequency component was calculated for the RR interval (measure of RSA) and systolic pressure, and the squared coherence and phase functions were assessed between RR and systolic pressure fluctuations in the respiratory band; a negative phase means that RR changes follow systolic pressure changes. The gain in the relationship between the two signal fluctuations was also calculated.

Results: Both β-blockers increased the mean (±SD) RR interval (placebo=808±21, nadolol=1,054±30, metoprolol=1,031±27 ms; p<0.0001), RSA (placebo=542, nadolol=1,177, metoprolol 1,316 ms2; p=0.002), and the gain (placebo=13.6±1.5, nadolol=21.9±2.8, metoprolol=24.5±3.6 ms/mm Hg; p<0.002), and both modified the phase function (placebo=minus21.1±5.3, nadolol=minus1.8±4.9, metoprolol=minus2.9±4.2 degree; p<0.0001). No difference was found between nadolol and metoprolol.

Conclusions: Chronic β-adrenergic blockade enhanced both RSA and baroreflex gain and reduced the phase between the RR interval and systolic pressure oscillations. Since no difference was found between the hydrophilic and the lipophilic β-blockers, these changes seem to be due to a peripheral effect.

Key Words: baroreflex sensitivity • cross-spectral analysis • humans • hydrophilic β-blockers • lipophilic β-blockers • metoprolol • nadolol • respiratory sinus arrhythmia • vagal activity

Submitted on July 24, 1997
Accepted on December 1, 1997




This article has been cited by other articles:


Home page
CirculationHome page
C. Cogliati, S. Colombo, T. G. Ruscone, D. Gruosso, A. Porta, N. Montano, A. Malliani, and R. Furlan
Acute {beta}-Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution
Circulation, November 2, 2004; 110(18): 2786 - 2791.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. V. Pitzalis, F. Massari, C. Forleo, A. Fioretti, R. Colombo, C. Balducci, F. Mastropasqua, and P. Rizzon
Respiratory Systolic Pressure Variability During Atrial Fibrillation and Sinus Rhythm
Hypertension, November 1, 1999; 34(5): 1060 - 1065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.